strains no. RG874 and RG886 from Dr Ruth E. Gordon, Rutgers State University, New Jersey, USA, and strains no. W2 and W4 from Professor B. W. Lacey, Westminster Hospital Medical School, London.
Antimicrobial agents. Solutions of fusidic acid, sulphamethoxazole and sulphadiazine were freshly prepared before each experiment. Sulphadiazine is the sulphonamide used most widely in the treatment of nocardiosis (Peabody and Seabury; Hoeprich, Brandt and Parker, 1968) , but it was decided to test another sulphonamide in parallel with it because of the description by Neipp (1964, cited by Garrod and O'Grady, 1968, p. 15) of variation in the in-vitro activity of sulphonamides. Fusidic acid is freely soluble, but the sulphonamides could be dissolved only at an alkaline pH, although once this had been achieved it was found possible to re-adjust thepH of the solution to 7.5 without precipitation occurring.
Media. For the estimation of MICs, sulphonamide inhibitors were neutralised by adding lysed horse blood to Diagnostic Sensitivity Test Agar (Oxoid-CM261) to a final concentration of 5 per cent. Lysed horse blood added to the fusidic acid plates doubled the MIC, an effect probably attributable to protein-binding of the drug and akin to that observed when sensitivity-testing to fusidic acid is carried out by the disk-diffusion method on blood-agar plates (Garrod and O'Grady, p. 436). Estimation of MIC. Dilutions of the agents were made in nutrient broth (Oxoid CMl), 1 ml of each dilution being added to a volume of melted Diagnostic Sensitivity Test (DST) Agar (Oxoid-CM261) to give h a 1 concentrations ranging from 50 to 0.312 pg per ml. When sulphonamides were tested, lysed horse blood at a final concentration of 5 per cent. was added. Plates were then poured. An inoculum of approximately 105-106 organismsprepared from a 6-hr mechanically agitated culture in 10 ml of nutrient broth containing 0.5 ml Tween 80-was added to every plate with a loop delivering 0.0025 ml. This inoculum was spread over an area of about 1 cm2. The plates were incubated at 37°C for 48 hr and the MIC was read as the highest dilution of the antibiotic that inhibited obvious bacterial growth. 
RESULTS
These are shown in the table, where it can be seen that the MIC of fusidic acid was less than that of the sulphonamides in three instances, equal to that of the sulphonamides in three, and greater than that of the sulphonamides in six. If, however, N. asteroides alone is considered, the MIC of fusidic acid was less than that of the sulphonamides in three instances, equal to that of the sulphonamides in three, and greater than that of the sulphonamides in three. These experiments were repeated several times and, with the exception of strain no. NCTC6761 which was inhibited by varying concentrations of sulphadiazine, the results were remarkably consistent. Although superficial skin lesions can occur, the characteristic clinical picture of nocardiosis is that of a recalcitrant, localised lung lesion that resembles pulmonary actinomycosis in some respects, but differs both in its histopathological appearances and also in displaying a striking predilection to metastasise to the brain.
There is still a very high fatality rate in this condition even when it is correctly diagnosed and treated. For example, in a recent survey of 148 cases, Hoeprich et al. (1968) reported a fatal outcome in about 87 per cent. of patients with cerebral involvement and 10 per cent. of patients with uncomplicated pulmonary nocardiosis who had been treated with sulphonamides. In view of these depressing results, it is interesting that two recent publications report successful treatment of nocardiosis with a combination of sulphonamides and other microbial agents as suggested by Peabody and Seabury (1960) . Hoeprich et al. give details of successful therapy of cerebral nocardiosis with sulphonamides and cycloserine, and Vasarinsh (1 968) describes: the successful outcome of a case of primary cutaneous nocardiosis treated with a combination of sulphadiazine, erythromycin and Sulfone. However, these reports and also the possible synergic effect of trimethoprim and sulphonamides on Nocardia species (Baikie, Macdonald and Mundy, 1970; Black and McNellis, 1970) still await further clinical evaluation. In the meantime, any new therapeutic agent that promises to be of value in the treatment of nocardiosis is obviously worth consideration.
The MICs of fusidic acid for Nocardia asteroides ranged from 0.625 pg per ml to 5.0 pg per ml, the value most frequently found being 2.5 pg per ml. Although the MIC first found for strain N1 (0.625 pg per ml) was not found with any of the other strains studied, the median value of 2.5 pg per ml is still within the range of therapeutic usefulness. With oral fusidic acid in normal dosage, plasma concentrations of 11-41 pg per ml are obtainable after 24 hr and these rise to 30-144pg per ml after 96 hours' therapy as a result of accumulation of the drug (Garrod and O'Grady, 1968, p. 202) . This means that the plasma concentration during treatment would exceed the MIC by a factor of between 12 and almost 60, a value considerably in excess of the usual factor of 2 or 4 considered satisfactory in the normal control of antibiotic therapy (Stokes, 1968) .
Fusidic acid might be of value in treating the pulmonary lesions of nocardiosis, both by virtue of its excellent penetration into avascular areas (Stewart, 1964; Hierholzer et al., 1966) and also of its relative freedom from side-effects-an important consideration when the treatment of nocardiosis may need to extend over several months. It would, however, be of very limited value as the sole therapeutic agent in the treatment of cerebral nocardiosis because of its poor penetration into the central nervous system.
The correlation of in-vitro findings with the clinical situation in man is notoriously difficult, but these results justify consideration of fusidic acid, either alone or preferably in conjunction with sulphonamides, for dealing with the intractable lesions of nocardiosis.
The superior in-vitro activity of sulphamethoxazole compared with that of sulphadiazine suggests that the former may be of some value in treating pulmonary nocardiosis. The latter, however, is preferable for the treatment of the cerebral lesions because of the high concentrations of drug that appear in the cerebrospinal fluid (Garrod and O'Grady, p. 38).
SUMMARY
The MICs of fusidic acid and two sulphonamides for nine strains of Nocardia asteroides, two strains of N. caviae and one strain of N. bZackwellii were studied by means of a platedilution technique. The median value for the MIC of fusidic acid, 2.5 pg per ml, compared very favourably with those of the sulphonamides, and fusidic acid may well have a part to play in the treatment of nocardiosis.
